BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

149 related articles for article (PubMed ID: 27865780)

  • 1. RasIns: Genetically Encoded Intrabodies of Activated Ras Proteins.
    Cetin M; Evenson WE; Gross GG; Jalali-Yazdi F; Krieger D; Arnold D; Takahashi TT; Roberts RW
    J Mol Biol; 2017 Feb; 429(4):562-573. PubMed ID: 27865780
    [TBL] [Abstract][Full Text] [Related]  

  • 2.
    Pálfy G; Vida I; Perczel A
    Biomol NMR Assign; 2020 Apr; 14(1):1-7. PubMed ID: 31468366
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Characterization of a Ras mutant with identical GDP- and GTP-bound structures .
    Ford B; Boykevisch S; Zhao C; Kunzelmann S; Bar-Sagi D; Herrmann C; Nassar N
    Biochemistry; 2009 Dec; 48(48):11449-57. PubMed ID: 19883123
    [TBL] [Abstract][Full Text] [Related]  

  • 4. High-frequency 94 GHz ENDOR characterization of the metal binding site in wild-type Ras x GDP and its oncogenic mutant G12V in frozen solution.
    Bennati M; Hertel MM; Fritscher J; Prisner TF; Weiden N; Hofweber R; Spörner M; Horn G; Kalbitzer HR
    Biochemistry; 2006 Jan; 45(1):42-50. PubMed ID: 16388579
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Selection of phage-displayed fab antibodies on the active conformation of ras yields a high affinity conformation-specific antibody preventing the binding of c-Raf kinase to Ras.
    Horn IR; Wittinghofer A; de Bruïne AP; Hoogenboom HR
    FEBS Lett; 1999 Dec; 463(1-2):115-20. PubMed ID: 10601649
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Distinct dynamics and interaction patterns in H- and K-Ras oncogenic P-loop mutants.
    Sayyed-Ahmad A; Prakash P; Gorfe AA
    Proteins; 2017 Sep; 85(9):1618-1632. PubMed ID: 28498561
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The structural basis for the transition from Ras-GTP to Ras-GDP.
    Hall BE; Bar-Sagi D; Nassar N
    Proc Natl Acad Sci U S A; 2002 Sep; 99(19):12138-42. PubMed ID: 12213964
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The Ras-RasGAP complex: structural basis for GTPase activation and its loss in oncogenic Ras mutants.
    Scheffzek K; Ahmadian MR; Kabsch W; Wiesmüller L; Lautwein A; Schmitz F; Wittinghofer A
    Science; 1997 Jul; 277(5324):333-8. PubMed ID: 9219684
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Guanosine triphosphatase stimulation of oncogenic Ras mutants.
    Ahmadian MR; Zor T; Vogt D; Kabsch W; Selinger Z; Wittinghofer A; Scheffzek K
    Proc Natl Acad Sci U S A; 1999 Jun; 96(12):7065-70. PubMed ID: 10359839
    [TBL] [Abstract][Full Text] [Related]  

  • 10. DRoP: a water analysis program identifies Ras-GTP-specific pathway of communication between membrane-interacting regions and the active site.
    Kearney BM; Johnson CW; Roberts DM; Swartz P; Mattos C
    J Mol Biol; 2014 Feb; 426(3):611-29. PubMed ID: 24189050
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Regulation of the protein kinase Raf-1 by oncogenic Ras through phosphatidylinositol 3-kinase, Cdc42/Rac and Pak.
    Sun H; King AJ; Diaz HB; Marshall MS
    Curr Biol; 2000 Mar; 10(5):281-4. PubMed ID: 10712905
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Identification and characterization of a peptidic ligand for Ras.
    Gareiss PC; Schneekloth AR; Salcius MJ; Seo SY; Crews CM
    Chembiochem; 2010 Mar; 11(4):517-22. PubMed ID: 20082398
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A sensitive fluorescence monitor for the detection of activated Ras: total chemical synthesis of site-specifically labeled Ras binding domain of c-Raf1 immobilized on a surface.
    Becker CF; Hunter CL; Seidel RP; Kent SB; Goody RS; Engelhard M
    Chem Biol; 2001 Mar; 8(3):243-52. PubMed ID: 11306349
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Small-molecule modulation of Ras signaling.
    Spiegel J; Cromm PM; Zimmermann G; Grossmann TN; Waldmann H
    Nat Chem Biol; 2014 Aug; 10(8):613-22. PubMed ID: 24929527
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Live-cell imaging of endogenous Ras-GTP illustrates predominant Ras activation at the plasma membrane.
    Augsten M; Pusch R; Biskup C; Rennert K; Wittig U; Beyer K; Blume A; Wetzker R; Friedrich K; Rubio I
    EMBO Rep; 2006 Jan; 7(1):46-51. PubMed ID: 16282985
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Different structural requirements within the switch II region of the Ras protein for interactions with specific downstream targets.
    Moodie SA; Paris M; Villafranca E; Kirshmeier P; Willumsen BM; Wolfman A
    Oncogene; 1995 Aug; 11(3):447-54. PubMed ID: 7630628
    [TBL] [Abstract][Full Text] [Related]  

  • 17. What makes Ras an efficient molecular switch: a computational, biophysical, and structural study of Ras-GDP interactions with mutants of Raf.
    Filchtinski D; Sharabi O; Rüppel A; Vetter IR; Herrmann C; Shifman JM
    J Mol Biol; 2010 Jun; 399(3):422-35. PubMed ID: 20361980
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Nuclear magnetic resonance and molecular dynamics studies on the interactions of the Ras-binding domain of Raf-1 with wild-type and mutant Ras proteins.
    Terada T; Ito Y; Shirouzu M; Tateno M; Hashimoto K; Kigawa T; Ebisuzaki T; Takio K; Shibata T; Yokoyama S; Smith BO; Laue ED; Cooper JA
    J Mol Biol; 1999 Feb; 286(1):219-32. PubMed ID: 9931261
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Identification of the guanine nucleotide dissociation stimulator for Ral as a putative effector molecule of R-ras, H-ras, K-ras, and Rap.
    Spaargaren M; Bischoff JR
    Proc Natl Acad Sci U S A; 1994 Dec; 91(26):12609-13. PubMed ID: 7809086
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Novel, activated RAS mutations alter protein-protein interactions.
    Dalley BK; Cannon JF
    Oncogene; 1996 Sep; 13(6):1209-20. PubMed ID: 8808695
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.